Decreasing the MMP-2 and MMP-9 plasma levels after intraperitoneal treatment with liposomal Curcumin can constitute valuable markers for evaluating the risk of vascular complications associated with diabetes mellitus. This evidence concerns the gene MMP9 and diabetes mellitus.